Drug intelligence / Profile preview

Xiaoyu Xiezhuo Yin

Development stage
Unknown
Lead developer
Zhejiang Hospital of Traditional Chinese Medicine
Administration
Oral
01

Overview

Xiaoyu Xiezhuo Yin (also known as Xiaoyu Xiezhuo Decoction or XXD) is a Traditional Chinese Medicine (TCM) herbal formula derived from the classical 'Buyang Huanwu Decoction.' It is composed of six primary herbs: *Astragalus membranaceus*, processed *Radix cyathulae*, Peach Kernel (*Prunus persica*), Lumbricus (*Pheretima*), prepared Rhubarb (*Rheum palmatum*), and Plantain (*Plantago asiatica*). The formula is primarily investigated for its therapeutic potential in kidney-related conditions, including chronic kidney disease (CKD), acute kidney injury (AKI), and diabetic kidney disease. Its mechanism of action involves the modulation of the TGF-β1/Smad3 and HIF1 signaling pathways, regulation of the gut–kidney axis, and inhibition of the aldosterone/MR/SGK-1 signaling pathway to reduce renal interstitial fibrosis. Research is largely conducted by academic and hospital-based groups in China, such as the Zhejiang Hospital of Traditional Chinese Medicine.

Other names
Xiaoyu Xiezhuo DrinkXiaoyu Xiezhuo DecoctionYiqi Jianpi Xiaoyu Xiezhuo Decoction
02

Targets

HIF1A (Hypoxia-inducible factor 1-alpha)MR (Mineralocorticoid receptor)SGK1SMAD3 (SMAD family member 3)TGFB1 (Transforming growth factor Beta-1 proprotein)

Beyond the preview

Go deeper on Xiaoyu Xiezhuo Yin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Xiaoyu Xiezhuo Yin.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call